Drug Patent Watch

JUNE 16, 2024

Annual Drug Patent Expirations for RECARBRIO Recarbrio is a drug marketed by Msd Merck Co and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.

Drugs 59

Drugs Marketing 59

Drugs.com

JUNE 16, 2024

SUNDAY, June 16, 2024 -- Exploring Europe, taking an African safari, going on a trip to the tropics: In many cases, vaccines are needed for travel, and that's doubly true for children. According to pediatrician Dr. Lauren Nguyen, researching what.

Vaccine 59

Vaccine International Research 59

Drug Patent Watch

JUNE 16, 2024

Annual Drug Patent Expirations for GAVRETO Gavreto is a drug marketed by Blueprint Medicines and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.

Drugs 59

Drugs Marketing 59

Drug Patent Watch

JUNE 16, 2024

Annual Drug Patent Expirations for PLUVICTO Pluvicto is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.

Drugs 59

Drugs Marketing 59

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

Drug Patent Watch

JUNE 16, 2024

Annual Drug Patent Expirations for INGREZZA+SPRINKLE Ingrezza Sprinkle is a drug marketed by Neurocrine and is included in one NDA. It is available from one supplier.

Drugs 59

Drugs Marketing 59

Drug Patent Watch

JUNE 16, 2024

This chart shows the patent expirations for tablet dosed drugs over the next decade. The term of drug patents varies.

Drugs 59

Drugs 59